The biggest risk at the moment was running out of money. Now they own the IP and have the money to develop it. So well done to the new CEO. Now the biggest risk is successful trials then approvals. A long haul but hopefully onward and upward.
TIS Price at posting:
4.0¢ Sentiment: Buy Disclosure: Held